L'dtude avait pour but de v~rifier les conditions d'intubation lors d'une induction ~ s~quence rapide utilisant la succinylcholine ou le vrcuronium comme myorelaxant. Les patients des Groupes Iet 11 recevaient un pr~-traitement avec de la d-tubocurarine O,05mg. kg -I suivi quatre minutes plus tard de succinylcholine 1,5 mg . kg-I. Les patients des Groupes !!1 et IV recevaient une dose d'amorce de vdcuronium de 0,01 rag. kg -I, suivie quatre minutes plus tard d'une dose de O, I mg. kg -I. Le ddlai entre l'administration du myorelaxant et l' intubation dtait de une minute dans les Groupes ! et Ill, alors que dans les Groupes il et IV ce d~lai ~tait de 90 sec. II n'y avait pas de diffdrence statistiquement significative dans les conditions d'intubation entre les Groupes Iet IV. Statistiquement, les moins bonnes conditions d' intubation se sont retrouv~es chez les patients du Groupe IH (v~curonium -ddlai d'une minute). Un d~lai de 90 sec aprds l'administration de la succinylcholine am~liorait significativement les conditions d' intubation chez les patients de sexe masculin. Etant donn6 que les conditions d' intubation des patients du groupe IV (vdcruonium-d~lai de 90 sec) n'~taient pas diff~rentes de celles des patients du
Rapid sequence induction of anaesthesia is a technique used in patients at risk of pulmonary aspiration to intubate the trachea rapidly and safely. Succinylcholine is the muscle relaxant used most frequently because of its rapid onset of action. However, succinylcholine has numerous side-effects which may lead to contraindications to its use. Pancuronium, in high doses, has been studied but its cardiovascular effects and prolonged duration of action make it unsuitable for use in a rapid induction sequence. The introduction of shorter-acting relaxants with fewer side-effects has stimulated several investigators to use these drugs for rapid tracheal intubation. Several studies CAN J ANAESTH 1990 / 37 : 3 /pp. 296-300 have reported contradictory results using vecuronium in the rapid sequence technique. 1-9 This may be for several reasons. First, most investigators have failed to reproduce the clinical conditions of rapid induction, since patients were already anaesthetized when the neuromuscular relaxant (NMR) was given. I-5 Furthermore, cricoid pressure was applied in only two studies. 6-7 Second, the doses used for precurarization and paralysis varied above or below the clinically recommended dosages. 4's Third, usually small numbers of patients have been studied.l-3'5-9 Fourth, intubating conditions may have been assessed by several investigators, decreasing the sensitivity of the measurement. 9 Finally, intubation 90 sec after non-depolarizing NMR administration, as recommended by Savarese, I~ was carried out in one study s but without comparison with intubation after 60 sec.
We undertook this study to compare intubating conditions after a standard rapid sequence induction with suecinylcholine II with those obtained with vecuronium, using the optimal priming sequence, j2 Because of the slower onset of action of vecuronium we also wished to verify whether there was any advantage in intubating 90 sec rather than 60 sec after administering the NMR.
Methods
This randomized double-blind study was approved by the Ethics Committee of Maisonneuve-Rosemont Hospital. Informed consent was obtained from all patients. One hundred and twenty-three patients, ASA physical status I-II, who were to undergo surgery necessitating tracheal intubation, were randomly allocated into four groups. Patients were excluded if there were potentially difficult intubating conditions, if they were taking medication known to interfere with neuromuscular relaxants, if they had neuromuscular or cardiac disease or if there were any contraindications to the use of succinylcholine. Most patients were premedicated with lorazepam 1-2 mg SL. After installation of ECG and non-invasive blood pressure monitoring, all patients received fentanyl 2 p.g. kg-~ and the precurarization or priming dose of NMR at time 0. At one minute, 100 per cent oxygen was administered via face mask. At four minutes, thiopentone 5 mg. kg-~ and Vocal cords adducted; difficult visualization; gross movement of the extremities and coughing with tracheal intubation the NMR were given as an IV bolus. Cricoid pressure was applied when patients lost consciousness. Direct laryngoscopy was performed and the trachea intubated with a cuffed tracheal tube 60 sec (Groups I and IIl) or 90 sec (Groups II and IV) after injection of the paralysing dose of NMR.
Patients in Groups 1 and 11 received a precurarizing dose of d-tubocurarine 0.05 mg'kg -I, followed by a paralysing dose of succinylcholine 1.5 mg-kg-i. Groups 1II and IV received a priming dose of vecuronium 0.01 rag. kg-1, followed by a paralysing dose of 0.1 mg-kg-t (Table I) . Coded syringes were prepared by an assistant and contained either d-tubocurarine or vecuronium, adjusted with saline to a uniform volume of 3 ml for the injection at time 0, or succinylcholine or vecuronium, adjusted with saline to a uniform volume of 10 ml for injection at four minutes. All intubations were performed by the same investigator (AB) who assessed intubating conditions according to the scale described by Fahey ~3 (Table 11 ) and was unaware of the relaxant sequence. Neuromuscular blockade was monitored with a nerve stimulator (Digistim II -Neurotechnology) using trainsof-four (TOF) every ten seconds. The ulnar nerve was stimulated via surface electrodes and supramaximal stimulation was assessed by the method described by Kopman. 14 The neuromuscular response was assessed visually by a second observer. Onset time was defined as the delay from injection of NMR until disappearance of TOF. Results are expressed as mean ---standard deviation (SD). Chi-square and analysis of variance were used to compare the groups. A P < 0.05 was considered significant.
Results
There were no statistically significant differences between groups with respect to age, gender, weight, ASA physical status, premedication, or type of surgery (Table  III) . Three patients were excluded from the study; one had not received medications according to the planned sequence, and in two others technical problems delayed Table IV . lntubating conditions were significantly better in Group II (succinylcholine -delay of 90 sec) than in the other three groups. There was no statistically significant difference between Groups I and IV (succinylcholinedelay of 60 see vs vecuronium -delay of 90 sec). The intubating conditions in Group III (vecuronium -delay of 60 sec) were significantly inferior to the other three groups, irrespective of gender.
Intubating conditions were independent of the patient's age or weight, but were significantly affected by gender (Table V) . Overall, conditions were more favourable in females than males. Males in Group II had significantly better intubation scores than males in the other groups. In females of Group II, conditions were not different from those in Groups I and IV.
Onset time of neuromuscular blockade was significantly longer in the groups receiving vecuronium than in those receiving succinylcholine (Table VI) .
Discussion
Rapid muscle relaxation and ideal intubating conditions are essential for a rapid sequence induction of anaesthesia. We were interested, above all, in the intubating conditions which we considered more important than the level of neuromuscular blockade, measured by ulnar nerve stimulation. Furthermore, this study attempted to reproduce faithfully the clinical practice of rapid sequence induction with regards to the drugs used and the application of cricoid pressure. All intubations were performed and scored by a single observer.
Intubating conditions after vecuronium, administered according to the priming principle and followed by an apnoeic period of 90 sec, were comparable with those after succinylcholine followed by a delay of 60 sec before laryngoscopy, the "gold standard" for rapid tracheal intubation. Forty-six per cent of patients intubated 60 sec after administration of identical doses of vecuronium had intubating scores of two or three. We consider this unacceptable for a rapid induction regimen. ~5
In Group IV it is interesting to note that satisfactory intubating conditions were obtained before complete abolition of muscle contractions. This agrees with the report by Fahey 13 and is further supported by Chauvin 16 who showed that vecuronium 0.1 mg'kg -~ produced diaphragmatic paralysis in 1.6 min while paralysis of the adductor pollicis took 2.5 rain. This study supports the concept that "observation of intubation conditions constitutes a more clinically relevant end-point than the measurement of adductor pollicis response. ''17 A similar dose of NMR (in mg. kg-i) produced overall better intubating conditions in females. In males, a delay of 90 sec after succinylcholine (Group II) significantly improved intubating conditions compared with the usual 60 see delay (Group I). Men in Group IV had similar (P > 0.05) intubating conditions to men in Group I, the "gold standard" for rapid sequence induction of anaesthesia. It should be noted ( Table V) that two males in Group I and three males in Group IV had unacceptable conditions for rapid tracheal intubation by our standards (intubating scores of two or three). Further study appears warranted to confirm these findings before recommending a change in accepted practice.
We used an interval of four minutes between the precurarizing and final dose of vecuronium as suggested by Taboada et al. 12 This agrees with the results of Baumgarten 9 and Naguib I8 and with the recommendations by Donati. 17 We also used the "ideal" priming and paralyzing doses proposed by Taboada et al., 12 i.e., 0.01 mg.kg -I and 0.1 mg'kg -~ of vecuronium. Donati ~7 recommends the use of smaller priming doses, 0.005 rag. kg-i of vecuronium, based on a report of respiratory function tests performed after priming with nondepolarizing neuromuscular relaxants. ~9 This study showed that vecuronium in doses of 0.005 mg" kg -~ and 0.01 mg-kg -I significantly reduced the TOF ratio and this reduction was greater in those patients who had received doses of 0.01 mg.kg -t. Vecuronium 0.01 mg. kg-1 significantly reduced peak expiratory flow rate from 475 to 460 L.min -I in these patients but the respiratory rate, vital capacity, and inspiratory force remained unchanged. Also, the signs and symptoms of curarization were no different between the two groups. Considering the above and given that the dose of 0.005 mg-kg -I was found to be less effective clinically than 0.01 mg.kg-I, I'7~ we chose to administer a priming dose of 0.01 mg. kg -1 vecuronium. Priming doses greater than 0.01 mg.kg -I offer no advantage, may produce important symptoms of curarization t2'19 and, finally, render the patient vulnerable to pulmonary aspiration. 2~ Savarese I~ suggested a delay of 90 sec apnoea when using a rapid induction technique with a non-depolarizing neuromuscular relaxant. The delay of 90 sec may lead to the possibility of hypoxaemia and redistribution of induction agents. We measured oxygen saturation in several patients and did not observe desaturation after 60 or 90 sec of apnoea. Preoxygenation for three minutes allows arterial oxygen saturation to be maintained greater than 95 per cent for up to eight minutes of apnoea in the normal patient, 21 and for 2 min 20 sec in the pregnant patient. 6 We did not have ability to evaluate the redistribution of anaesthetic induction agents but, given the doses used, we did not feel that supplementation was necessary at the time of intubation.
In conclusion, similar intubating conditions for a rapid sequence induction of anaesthesia may be achieved with the use of vecuronium or succinylcholine in the doses described in this study, provided a longer period of time is allowed before laryngoscopy when vecuronium is chosen to facilitate tracheal intubation. However, the optimal dosage of NMR and/or ideal delay before intubation may have to be redefined in men, since a clinically significant proportion of them presented unacceptable intubating conditions despite the use of generally accepted regimens for rapid sequence induction of anaesthesia.
